These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6292712)

  • 41. Antifungal agents. VI. In vitro antifungal activities of halobenzoyl esters of cis- and trans-[2-(1,1'-biphenyl-4-yl)-2-(1H-imidazol-1-ylmethyl)-1,3- dioxolan-4-yl]carbinols.
    Stefancich G; Silvestri R; Pagnozzi E; Artico M; Retico A; Apuzzo G; Simonetti N
    Farmaco; 1993 Aug; 48(8):1103-12. PubMed ID: 8216672
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combined activity of ketoconazole and 5-fluorocytosine on potentially pathogenic yeasts.
    Beggs WH; Sarosi GA
    Antimicrob Agents Chemother; 1982 Feb; 21(2):355-7. PubMed ID: 6280603
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Researches on antibacterial and antifungal agents, XII: Analogues of bifonazole with two imidazole moieties and related azoles.
    Stefancich G; Silvestri R; Panico S; Artico M; Simonetti N
    Arch Pharm (Weinheim); 1990 May; 323(5):273-80. PubMed ID: 2200385
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of the antifungal activity of fenticonazole on strains of Candida albicans on cellular lines.
    Cusumano V; Costa AL; Veronese M
    Mykosen; 1985 May; 28(5):238-43. PubMed ID: 3892289
    [No Abstract]   [Full Text] [Related]  

  • 45. Azole resistance in Candida albicans.
    Smith KJ; Warnock DW; Kennedy CT; Johnson EM; Hopwood V; Van Cutsem J; Vanden Bossche H
    J Med Vet Mycol; 1986 Apr; 24(2):133-44. PubMed ID: 3014106
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ketoconazole.
    Jones HE
    Arch Dermatol; 1982 Apr; 118(4):217-9. PubMed ID: 6279033
    [No Abstract]   [Full Text] [Related]  

  • 47. Antifungal agents. 7. Dichlorophenylpyrrylimidazolylmethane derivatives: synthesis and antifungal activities.
    Massa S; Mai A; Ragno R; Porretta GC; Retico A; Simonetti G; Artico M
    Farmaco; 1994 Jan; 49(1):51-5. PubMed ID: 8185750
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Preliminary experiences in the treatment of onychomycosis with ketoconazole].
    Trost T
    Z Hautkr; 1983 Apr; 58(8):580-5. PubMed ID: 6305047
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Comparative action of 8 azole derivatives against Candida albicans: fungistatic action and cytologic study by scanning electron microscopy].
    Mallie M; Jouvert S; Bastide M; Montes B; Lebecq JC; Bastide JM
    Pathol Biol (Paris); 1988 May; 36(5):575-80. PubMed ID: 3043361
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ketoconazole and the Actinomycetales.
    Martin MV
    Lancet; 1982 Apr; 1(8275):807. PubMed ID: 6121258
    [No Abstract]   [Full Text] [Related]  

  • 51. Ketoconazole--an antifungal drug for oral use.
    Drug Ther Bull; 1981 Nov; 19(23):91-2. PubMed ID: 6269823
    [No Abstract]   [Full Text] [Related]  

  • 52. Effect of methotrexate alone and in combination with antifungal drugs on the growth of Candida albicans.
    Warnock DW; Johnson EM; Burke J; Pracharktam R
    J Antimicrob Chemother; 1989 Jun; 23(6):837-47. PubMed ID: 2547749
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro antifungal activities of Bay n 7133 and Bay L 9139, two new orally absorbed antifungal imidazole derivatives, against pathogenic yeasts.
    Fromtling RA; Yu HP; Shadomy S
    Mycopathologia; 1984 Apr; 86(1):45-50. PubMed ID: 6330557
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Study of the morphofunctional alterations produced by fenticonazole on strains of Candida albicans, using the scanning electron microscope (S.E.M).
    Costa AL; Valenti A; Veronese M
    Mykosen; 1984 Jan; 27(1):29-35. PubMed ID: 6366540
    [No Abstract]   [Full Text] [Related]  

  • 55. Antifungal agents. VIII. Synthesis and antifungal activities of bipyrryl analogues of bifonazole.
    di Santo R; Massa S; Costi R; Simonetti G; Retico A; Apuzzo G; Troccoli F
    Farmaco; 1994 Apr; 49(4):229-36. PubMed ID: 8049002
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro comparative study of the fungistatic and fungicidal activity of sertaconazole and other antifungals against Candida albicans.
    Palacín C; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1992 May; 42(5A):711-4. PubMed ID: 1627188
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Promotion of pseudomycelium formation of Candida albicans in culture: a morphological study of the effects of miconazole and ketoconazole.
    Borgers M; De Brabander M; Van Den Bossche H; Van Cutsem J
    Postgrad Med J; 1979 Sep; 55(647):687-91. PubMed ID: 392485
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antimicrobial activity of a new derivative: N-(4-chlorobenzyl)-2-(1H-imidazol-1-ylmethyl)benzenamine.
    Panico S; Villa A; Simonetti N; Porretta GC; Scalzo M
    Drugs Exp Clin Res; 1990; 16(4):181-6. PubMed ID: 2076654
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The antifungal effects of tioconazole aerosol form].
    Canefe K; Ozyurt C
    Mikrobiyol Bul; 1991 Jan; 25(1):63-70. PubMed ID: 1881361
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Successful treatment of chronic esophageal candidosis with oral ketoconazole.
    Rutgeerts LJ; Symoens J
    Mykosen; 1982 Aug; 25(8):429-30. PubMed ID: 6290883
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.